SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-003522
Filing Date
2017-05-04
Accepted
2017-05-04 16:15:00
Documents
63
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20170331x10q.htm 10-Q 899756
2 EX-10.1 idra-20170331ex1013c0f0a.htm EX-10.1 146685
3 EX-10.2 idra-20170331ex10245b890.htm EX-10.2 128669
4 EX-31.1 idra-20170331ex311f88637.htm EX-31.1 14403
5 EX-31.2 idra-20170331ex312ffc7c9.htm EX-31.2 14413
6 EX-32.1 idra-20170331ex32186af54.htm EX-32.1 6703
7 EX-32.2 idra-20170331ex3220233b7.htm EX-32.2 6543
  Complete submission text file 0001558370-17-003522.txt   3928348

Data Files

Seq Description Document Type Size
8 EX-101.INS idra-20170331.xml EX-101.INS 763594
9 EX-101.SCH idra-20170331.xsd EX-101.SCH 32341
10 EX-101.CAL idra-20170331_cal.xml EX-101.CAL 39194
11 EX-101.DEF idra-20170331_def.xml EX-101.DEF 83298
12 EX-101.LAB idra-20170331_lab.xml EX-101.LAB 223529
13 EX-101.PRE idra-20170331_pre.xml EX-101.PRE 180500
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 17814104
SIC: 2836 Biological Products, (No Diagnostic Substances)